These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3530620)

  • 41. [Bronchospasmolytic effectiveness of controlled drug combinations].
    Forche G; Zenker G; Harnoncourt K
    Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
    Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bronchodilator action of drug combinations in asthmatic patients. Ephedrine, theophylline and tranquilizing drugs.
    Muittari A; Mattila MJ
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):374-85. PubMed ID: 4996224
    [No Abstract]   [Full Text] [Related]  

  • 44. Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
    Dini FL; Cogo R
    Curr Med Res Opin; 2001; 16(4):258-68. PubMed ID: 11268710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y; Liu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacologic management of chronic obstructive pulmonary disease.
    Fairshter RD
    Compr Ther; 1984 Mar; 10(3):12-9. PubMed ID: 6713810
    [No Abstract]   [Full Text] [Related]  

  • 47. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Management of patients with chronic obstructive pulmonary disease].
    Coll R; Morera J
    Rev Clin Esp; 1994 Dec; 194(12):1049-57. PubMed ID: 7863055
    [No Abstract]   [Full Text] [Related]  

  • 49. A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
    van As A; Benjamin C; Stern JD
    Scand J Respir Dis; 1973; 54(1):28-37. PubMed ID: 4690403
    [No Abstract]   [Full Text] [Related]  

  • 50. [Theophylline in the therapy of non reversible airway obstruction].
    Drigo R; Bevilacqua M; Franco R
    G Clin Med; 1987 Jan; 68(1):39-45. PubMed ID: 3301490
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of theophylline and proxyphylline in the treatment of obstructive lung diseases in children: demands for new dosage routines].
    Holmen TL; Selvig K; Bjerve KS; Aas K; Rugstad HE
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):172-73. PubMed ID: 7385142
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of respiratory insufficiency in chronic nonspecific lung diseases].
    Kazanbiev NK
    Klin Med (Mosk); 1995; 73(4):24-7. PubMed ID: 7474811
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Toxic dermatitis induced by bamifylline. 2 cases].
    Carsuzaa F; Schranz J
    Presse Med; 1993 Mar; 22(10):494. PubMed ID: 8511075
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Theophylline-niacinamide in the relief of bronchospasm.
    Practitioner; 1967 Feb; 198(184):289-91. PubMed ID: 5341594
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis.
    Cogo R; Castronuovo A
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):15-20. PubMed ID: 11409184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sympathomimetic xanthine broncholysis in obstructive ventilatory disorders.
    Cohen BM; Elizabeth NJ
    Int J Clin Pharmacol; 1974 Jan; 9(1):6-15. PubMed ID: 4593130
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical study of the broncho-relaxing action of a new sympathicomimetic drug on twenty patients with chronic obstructive lung disease (author's transl)].
    Sergysels R; Leblanc G; Payfa M; Hennebert A
    Acta Tuberc Pneumol Belg; 1973; 64(1):80-8. PubMed ID: 4768064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.